For moderate acne vulgaris, which regimen is appropriate?

Study for the PANCE Precision Exam. Improve with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

For moderate acne vulgaris, which regimen is appropriate?

Explanation:
Moderate acne vulgaris typically needs both a topical regimen and systemic treatment to control different aspects of the disease. The topical part tackles abnormal desquamation and bacterial colonization at the skin surface, helping to prevent new comedones and reduce localized inflammation. Adding an oral antibiotic provides systemic anti-inflammatory and antibacterial effects, reducing inflammatory lesions more effectively than a topical approach alone. This combination targets both the comedonal component and the inflammatory component, offering better overall clearance in moderate cases. Oral isotretinoin, while highly effective, is generally reserved for severe, nodulocystic, or refractory acne due to its potential for significant adverse effects and teratogenicity. Azelaic acid, although beneficial, is often not sufficient on its own for moderate disease and is more commonly used as an adjunct rather than the primary approach in this severity.

Moderate acne vulgaris typically needs both a topical regimen and systemic treatment to control different aspects of the disease. The topical part tackles abnormal desquamation and bacterial colonization at the skin surface, helping to prevent new comedones and reduce localized inflammation. Adding an oral antibiotic provides systemic anti-inflammatory and antibacterial effects, reducing inflammatory lesions more effectively than a topical approach alone. This combination targets both the comedonal component and the inflammatory component, offering better overall clearance in moderate cases.

Oral isotretinoin, while highly effective, is generally reserved for severe, nodulocystic, or refractory acne due to its potential for significant adverse effects and teratogenicity. Azelaic acid, although beneficial, is often not sufficient on its own for moderate disease and is more commonly used as an adjunct rather than the primary approach in this severity.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy